Penn Med COVID-19 vaccine phase 1 trial elicits immune response in all participants

Get our award-winning print editions of The Daily Pennsylvanian delivered to your doorstep every week.

The COVID-19 vaccine evolved through the Wistar Institute and Penn Medicine enters two trials in September.

RELATED:

Penn Medicine Receives $ 2.5 Million Grant for COVID Watch Program

Wistar Institute and Penn Medicine Begin Human Coronavirus Vaccine

Get our newsletter, Dear Penn, delivered to your inbox every morning of the week.

Leave a Comment

Your email address will not be published. Required fields are marked *